During early February 2023, BioEleSonic attended Biotechgate Digital Partnering: a five-day virtual conference for key players in the biotech, medtech and pharma fields.
With the focus on development, licensing and collaboration, over 5’000 participating companies were given a key forum to connect with potential partners, investors and knowledge experts in relevant sectors. BioEleSonic leveraged this space to showcase its product, meet potential partners and drive future clinical development of its patented technology BES-1001.
You can find out more information about BioEleSonic here.
